Facilities Must Stop Using Custom Ultrasonics' System To Reprocess Duodenoscopes, FDA Warns
Executive Summary
The US agency issued a safety communication Aug. 17 advising all health care facilities to stop using Custom Ultrasonics' System 83 Plus automated endoscope reprocessors to reprocess duodenoscopes, although facilities may continue to use the AERs to clean and sterilize other flexible endoscopes.
You may also be interested in...
FDA Clears Validation Testing For Automated Endoscope Reprocessors
FDA has found that validation test data for three automated endoscope reprocessors – including Medivators’ Advantage Plus and DSD Edge, and Steris’ System 1E Liquid Chemical Sterilant Processing System – are adequate.
FDA Orders Custom Ultrasonics To Recall All Endoscope Reprocessors
The rare recall order comes as a result of a consent-decree violation by the company, which supplies endoscope reprocessors to almost 3,000 hospitals nationwide. FDA says Custom Ultrasonics has failed to validate its device designs, among other concerns.
FDA Announces Two More Medical Device Consent Decrees
FDA has already completed three consent decrees blocking sales of medical devices in 2007, with two surfacing last week. The agency has not obtained more than two device-related injunctions in any of the previous six years